Collaborative study on monitoring methods to determine direct thrombin inhibitors lepirudin and argatroban.
Gray
E
E
Division of Haematology, National Institute for Biological Standards and Control, Hertfordshire, UK.
Harenberg
J
J
D001120:Arginine / Q000031:analogs & derivatives; D001780:Blood Coagulation Tests / Q000379:methods / Q000592:standards; D003299:Cooperative Behavior; D016903:Drug Monitoring / Q000379:methods* / Q000592:standards; D004797:Enzyme-Linked Immunosorbent Assay / Q000592:standards; D005343:Fibrinolytic Agents / Q000097:blood / Q000493:pharmacokinetics; D006629:Hirudins / Q000097:blood / Q000493:pharmacokinetics*; D006801:Humans; D008722:Methods; D010875:Pipecolic Acids / Q000097:blood / Q000493:pharmacokinetics*; D011994:Recombinant Proteins / Q000097:blood / Q000493:pharmacokinetics; D015203:Reproducibility of Results; D013449:Sulfonamides; D013917:Thrombin / Q000037:antagonists & inhibitors*
D005343:Fibrinolytic Agents; D006629:Hirudins; D010875:Pipecolic Acids; D011994:Recombinant Proteins; D013449:Sulfonamides; D001120:Arginine; D013917:Thrombin; C031942:argatroban; C083544:lepirudin